Semax
Heptapeptide analog of ACTH(4-10) studied in Russia for cognitive and neuroprotective effects after stroke.
Educational only — not medical advice. SmartPeptide does not prescribe, diagnose, or treat. Always consult a licensed healthcare provider before using any peptide, supplement, medication, or protocol.
What the research shows
Russian post-stroke and cognitive-performance studies; some BDNF/neurotrophic mechanism work.
What's still experimental
Limited western replication. Cognitive-enhancement claims in healthy adults need larger trials.
Anecdotal / community reports
Focus and clarity reports are common; outcomes depend on dose, formulation, and individual factors.
Anecdotal reports are NOT scientific evidence. They reflect personal experience and may not generalize.
Live research
Updated hourly · sourced from PubMed + ClinicalTrials.govKnown risks
Mostly Russian-source data; not approved by FDA.
Reported side effects
Limited safety data in Western populations.
What requires medical supervision
Not FDA-approved. Limited western safety data.
Questions for your clinician
- Is there independent (non-Russian) replication?
- What baseline cognitive testing would we do to track effect?